|Posts on Regator:||5246|
|Posts / Week:||66.9|
|Archived Since:||August 20, 2016|
CARACAS (Reuters) - Yasmira Castano felt she had a fresh chance at life when she received a kidney transplant almost two decades ago. The young Venezuelan was able to finish high school and went on to work as a manicurist.
WASHINGTON/NEW YORK (Reuters) - The U.S. government on Tuesday proposed extending the availability of skimpy health insurance plans to millions of Americans in another Trump administration move aimed at undercutting the requirements of the Affordable Care Act, often called Obamacare.
(Reuters) - U.S. drug developer Aimmune Therapeutics Inc said on Tuesday its peanut allergy drug met the main goal of an eagerly awaited late-stage study, sending its shares up 18 percent premarket.
SAO PAULO (Reuters) - Nestle SA will launch its first organic food line in Brazil in the coming weeks, an executive told Reuters, as the world's biggest food company makes a global push to capture growing interest in healthy and organic products.
JAKARTA (Reuters) - Indonesia seized a record 1.6 tonnes of crystal methamphetamine from a ship off the northern island of Batam on Tuesday, a narcotics official said, the second major drug bust this month.
LUSAKA (Reuters) - Zambia's cholera epidemic continues to slow with seven deaths recorded over the last month, Health Minister Chitalu Chilufya said on Tuesday.
LONDON (Reuters) - An outbreak of typhoid fever in Pakistan is being caused by an extensively drug resistant "superbug" strain, a sign that treatment options for the bacterial disease are running out, scientists said on Tuesday.
(Reuters Health) - Injuries to a critical ligament in the knee are becoming more common in children and teens, researchers warn.
(Reuters Health) - The number of babies dying of suffocation before their first birthday has been rising in recent years, driven at least in part by an increase in the number of parents sharing beds with their infants, a U.S. study suggests.
BLANTYRE (Reuters) - Cholera cases in Malawi have tripled and four more people have died, the Ministry of Health said on Monday, a month after the spread of the disease from Zambia was thought to have been contained.
(Reuters Health) - In the first year after being told by a doctor that they have acne, patients’ risk for a diagnosis of major depressive disorder spikes by more than 60 percent compared to the general population, a new study shows.
LONDON (Reuters) - AstraZeneca's immunotherapy drug Imfinzi has won crucial approval from U.S. regulators for use in lung cancer, opening up a multibillion-dollar market for a medicine that has so far lagged behind competitors.
(Reuters) - A federal judge in Delaware has overturned a jury's verdict requiring Gilead Sciences Inc to pay a record $2.54 billion because its hepatitis C drugs Sovaldi and Harvoni infringed a patent held by rival Merck & Co Inc.
(Reuters Health) - A shortage of clinicians specializing in pediatric behavioral and developmental disorders is translating into long wait times for new patient appointments amid surging demand, a new study suggests.
(Reuters) - The U.S. Food and Drug Administration on Friday granted approval for expanded use of AstraZeneca Plc's, immunotherapy drug, Imfinzi, to treat non-small cell lung cancer whose tumors can't be surgically removed.
(Reuters) - The U.S. Food and Drug Administration on Friday declined to approve Apricus Biosciences Inc's Vitaros, a cream to treat erectile dysfunction, for the second time in a decade, sending the company's shares down more than 70 percent before the opening bell.
(Reuters) - Switzerland's Novartis AG is preparing to auction its U.S. generic pill business, looking to shed a unit that has struggled amid fierce price competition, people familiar with the matter said on Friday.
(Reuters Health) - Even though elderly people have the highest rates of hospitalization and death from influenza, a U.S. study suggests that older patients may be less likely to get tested for flu in the hospital.
(Reuters Health) - What if someone who lived with the young man who unleashed one of the deadliest school shootings in U.S. history this week had been concerned that he might harm himself or others and removed his AR-15 rifle from his home?
TORONTO (Reuters) - Canopy Growth Corp, one of the world's biggest medical marijuana producers, now wants to take on the world's pharmaceutical giants.